文献速递主动脉疾病

Nellix-in-Nellix延伸术治疗EVAS失败患者的初步结局

Preliminary outcome of Nellix-in-Nellix extensions in patients treated with failed endovascular aneurysm sealing.
PubMed 文献 · J Vasc Surg · 2019-03-29

这项全球回顾性观察性队列研究分析了41例EVAS失败后行NINA手术的患者,择期组技术成功率94%,急诊组100%;择期组随访中位104天,动脉瘤相关死亡3例(9%),急诊组随访中位23天,动脉瘤相关死亡4例。结论认为NINA可用于EVAS晚期失败,但耐久性需进一步评估。

要点

  • NINA治疗EVAS失败的技术成功率择期组94%、急诊组100%。
  • 择期组随访中位104天,动脉瘤相关死亡3例(9%),无破裂。
  • 急诊组随访中位23天,动脉瘤相关死亡4例。

核心结论

  • NINA可用于治疗EVAS晚期失败,技术成功率可接受,可在既定治疗方案不可行或禁忌时使用,但耐久性需进一步评估。

研究设计与样本

  • 全球回顾性观察性队列研究,纳入11家欧洲机构和1家新西兰医院的数据,共41例EVAS失败后行NINA的患者。

主要发现

  • 择期NINA组32例(78%),急诊组9例(22%)。
  • 择期组技术成功率94%,急诊组100%。
  • 择期组随访中位104天(IQR 49-328天),动脉瘤相关死亡3例(9%),无破裂,器械相关再干预5例(16%)。
  • 急诊组随访中位23天(IQR 7-61天),动脉瘤相关死亡4例,动脉瘤相关再干预3例。
  • 择期组NINA指征:内漏伴迁移50%,内漏无迁移25%,迁移无内漏16%,其他9%。

关键数值与推荐

  • 择期组与急诊组从初次EVAS到NINA的平均时间分别为573天(IQR 397-1078天)和478天(IQR 120-806天)。
  • 择期组32例中21例使用烟囱移植物,急诊组9例中3例使用烟囱移植物。
  • 共7例初次EVAS采用烟囱EVAS(择期组5例,急诊组2例)。

临床怎么用

  • 对于EVAS失败且既定治疗方案不可行或禁忌的患者,可考虑NINA,但需注意其耐久性尚未充分证实。

局限性

  • 回顾性观察性设计,样本量41例,随访时间较短(择期中位104天,急诊中位23天),耐久性需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 1-year results of the use of the Nellix (Endologix Inc, Irvine, Calif) endovascular aneurysm sealing (EVAS) device were initially promising. However, midterm complications including migration and aneurysm growth occurred more frequently than expected, which provided an incentive to refine the instructions for use. Strategies for the management of complications arising after endovascular aneurysm repair are often not applicable for EVAS, given the unique configuration of the Nellix device, and new techniques are needed. This study analyzes the clinical outcomes of both elective and emergency deployment of a new Nellix device within a primarily placed device, for failure of EVAS, which we refer to as a Nellix-in-Nellix application (NINA). METHODS: This is a global, retrospective, observational cohort study focusing on the early outcome of NINA for failed EVAS, including data from 11 European institutions and 1 hospital in New Zealand. RESULTS: A total of 41 patients were identified who underwent a NINA procedure. Of these, 32 (78%) were placed electively and 9 (22%) were placed on an emergency basis. Seven patients were initially treated with chimney EVAS (n = 5 in the elective NINA group and n = 2 in the emergency NINA group). The average time between the primary EVAS procedure and NINA was 573 days (interquartile range, [IQR] 397-1078 days) and 478 days (IQR, 120-806) for the elective and emergency groups, respectively. The indication for elective NINA was endoleak with migration (50%), endoleak without migration (25%), migration without endoleak (16%), and other (9%). Chimney grafts were used in 21 of 32 patients in the elective group and 3 of 9 patients in the emergency group. Technical success was achieved in 94% of patients in the elective group and 100% of patients in the emergency group. At latest follow-up (median, 104 days; IQR, 49-328 days), there were three aneurysm-related deaths (9%), no ruptures, and five device-related reinterventions (16%) within the elective group. In the emergency group (median follow-up, 23 days; IQR, 7-61 days), there were four aneurysm-related deaths and three aneurysm-related reinterventions. CONCLUSIONS: In conclusion, a NINA can be used to treat late failures of EVAS with an acceptable technical success rate and can be used when more established treatment options are unfeasible or contraindicated. The durability of this technique needs to be further reviewed.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zoethout AC, Zerwes S, Zeebregts CJAM, et al. Preliminary outcome of Nellix-in-Nellix extensions in patients treated with failed endovascular aneurysm sealing. J Vasc Surg. 2019. PMID: 30935765. doi:10.1016/j.jvs.2019.01.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。